SG10202006681WA - Immunogenic compositions comprising lawsonia intracellularis - Google Patents
Immunogenic compositions comprising lawsonia intracellularisInfo
- Publication number
- SG10202006681WA SG10202006681WA SG10202006681WA SG10202006681WA SG10202006681WA SG 10202006681W A SG10202006681W A SG 10202006681WA SG 10202006681W A SG10202006681W A SG 10202006681WA SG 10202006681W A SG10202006681W A SG 10202006681WA SG 10202006681W A SG10202006681W A SG 10202006681WA
- Authority
- SG
- Singapore
- Prior art keywords
- immunogenic compositions
- lawsonia intracellularis
- intracellularis
- lawsonia
- immunogenic
- Prior art date
Links
- 241001148567 Lawsonia intracellularis Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/825—Bacterial vaccine for porcine species, e.g. swine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66135205P | 2005-03-14 | 2005-03-14 | |
US11/374,350 US8834891B2 (en) | 2005-03-14 | 2006-03-13 | Immunogenic compositions comprising Lawsonia intracellularis |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10202006681WA true SG10202006681WA (en) | 2020-08-28 |
Family
ID=36971208
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202006681WA SG10202006681WA (en) | 2005-03-14 | 2006-03-14 | Immunogenic compositions comprising lawsonia intracellularis |
SG2011068764A SG175555A1 (en) | 2005-03-14 | 2006-03-14 | Immunogenic compositions comprising lawsonia intracellularis |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011068764A SG175555A1 (en) | 2005-03-14 | 2006-03-14 | Immunogenic compositions comprising lawsonia intracellularis |
Country Status (14)
Country | Link |
---|---|
US (6) | US8834891B2 (ko) |
EP (4) | EP3354279A3 (ko) |
JP (2) | JP5832061B2 (ko) |
KR (1) | KR101315092B1 (ko) |
CN (1) | CN101175509B (ko) |
AU (1) | AU2006222906A1 (ko) |
BR (1) | BRPI0608439B1 (ko) |
CA (1) | CA2600877C (ko) |
DK (2) | DK2992897T3 (ko) |
ES (2) | ES2596307T3 (ko) |
MX (1) | MX2007011268A (ko) |
SG (2) | SG10202006681WA (ko) |
WO (1) | WO2006099561A1 (ko) |
ZA (1) | ZA200707799B (ko) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
US7833707B2 (en) * | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
US8398994B2 (en) * | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
EP2275132B1 (en) | 2005-12-29 | 2021-03-03 | Boehringer Ingelheim Animal Health USA Inc. | Multivalent PCV2 immunogenic compositions and methods of producing them |
EP2275130A3 (en) * | 2005-12-29 | 2011-03-23 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 ORF2 immunogenic composition |
US8470336B2 (en) * | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体 |
US20080241190A1 (en) * | 2006-11-13 | 2008-10-02 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of horses against lawsonia intracellularis |
US20100136060A1 (en) * | 2006-11-22 | 2010-06-03 | Boehringer Ingelheim Vetmedica, Inc. | Methods of reducing porcine circovirus-associated disease outbreaks |
EP2101815A4 (en) * | 2006-12-11 | 2010-10-06 | Boehringer Ingelheim Vetmed | EFFICIENT PROCESS FOR THE TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS |
MX2009006066A (es) | 2006-12-15 | 2009-06-17 | Boehringer Ingelheim Vetmed | Tratamiento de cerdos con el antigeno pcv. |
EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
CN101821284B (zh) * | 2007-08-03 | 2014-11-19 | 贝林格尔·英格海姆维特梅迪卡有限公司 | 猪痢疾短螺旋体的基因和蛋白质及其用途 |
US7829274B2 (en) * | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
US8398970B2 (en) * | 2007-09-17 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Method of preventing early Lawsonia intracellularis infections |
WO2009088950A2 (en) * | 2007-12-31 | 2009-07-16 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 orf2 virus like particle with foreign amino acid insertion |
BRPI0907438A2 (pt) | 2008-01-23 | 2015-08-04 | Boehringer Ingelheim Vetmed | Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições |
EP2254595A4 (en) * | 2008-02-15 | 2012-12-05 | Boehringer Ingelheim Vetmed | METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES |
TWI449533B (zh) | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗 |
UA100047C2 (ru) * | 2008-04-18 | 2012-11-12 | Интервет Интернешонал Б.В. | Вакцина для защиты от lawsonia intracellularis |
TWI551295B (zh) | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | 防備胞內勞森菌(Lawsonia intracellularis)用疫苗 |
US8142760B2 (en) | 2008-09-05 | 2012-03-27 | Nathan Len Winkelman | Vaccination for Lawsonia intracellularis |
TWI627281B (zh) | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物 |
CN102727883B (zh) * | 2011-05-27 | 2014-05-14 | 华威特(北京)生物科技有限公司 | 猪繁殖与呼吸综合征与猪瘟二联疫苗及其用途 |
US20140348867A1 (en) * | 2011-11-01 | 2014-11-27 | John Clare Samuel Harding | Isolated Brachyspira and Methods and Compositions for Expanding and Isolating Brachyspira |
CN102716482B (zh) * | 2012-03-07 | 2014-01-01 | 齐鲁动物保健品有限公司 | 一种高致病性猪繁殖与呼吸综合征活疫苗稀释液 |
RU2493569C1 (ru) * | 2012-08-21 | 2013-09-20 | Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Российской академии сельскохозяйственных наук (ГНУ ИЭВСиДВ Россельхозакадемии) | Способ диагностики лептоспироза сельскохозяйственных животных |
ES2922879T3 (es) | 2012-12-21 | 2022-09-21 | Boehringer Ingelheim Vetmedica Gmbh | Proteínas recombinantes novedosas de la membrana externa de Brachyspira hyodysenteriae y usos de las mismas |
AU2014329524B2 (en) | 2013-10-02 | 2019-01-17 | Boehringer Ingelheim Animal Health USA Inc. | PCV2 ORF2 protein variant and virus like particles composed thereof |
JP6484241B2 (ja) * | 2013-12-03 | 2019-03-13 | インターベット インターナショナル ベー. フェー. | PRRSおよびローソニア・イントラセルラリス(Lawsonia intracellularis)に対するブタワクチン |
RU2672251C1 (ru) * | 2013-12-03 | 2018-11-13 | Интервет Интернэшнл Б.В. | Вакцина против lawsonia intracellularis и свиного цирковируса 2-го типа |
CN104073450A (zh) * | 2014-02-28 | 2014-10-01 | 重庆市畜牧科学院 | 山羊源化脓隐秘杆菌及其应用 |
CN103937706B (zh) * | 2014-03-20 | 2016-08-17 | 北京和安恒盛生物科技有限公司 | 猪鼻支原体菌株及其灭活疫苗和应用 |
CN104749361B (zh) * | 2015-01-21 | 2017-04-19 | 中国农业科学院哈尔滨兽医研究所 | 猪圆环病毒2型抗原捕获elisa试剂盒 |
CN108697782A (zh) * | 2016-03-23 | 2018-10-23 | 英特维特国际股份有限公司 | 针对pcv2病毒和猪肺炎支原体感染的组合疫苗 |
WO2018099889A1 (en) * | 2016-11-29 | 2018-06-07 | Intervet International B.V. | Swine vaccine |
KR102665710B1 (ko) | 2017-08-24 | 2024-05-14 | 노보 노르디스크 에이/에스 | Glp-1 조성물 및 그 용도 |
CN110981945B (zh) * | 2019-12-08 | 2021-10-19 | 中牧实业股份有限公司 | 一种猪圆环病毒2型重组Cap蛋白的表达制备及应用 |
US20230082544A1 (en) | 2020-02-18 | 2023-03-16 | Novo Nordisk A/S | Pharmaceutical formulations |
US20230241198A1 (en) * | 2020-07-24 | 2023-08-03 | Boehringer Ingelheim Animal Health USA Inc. | Combination porcine vaccine |
US20230141226A1 (en) * | 2021-11-01 | 2023-05-11 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic gel compositions |
Family Cites Families (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US3479430A (en) * | 1967-08-24 | 1969-11-18 | Diamond Lab Inc | Indirect passive immunization against transmissible gastroenteritis virus in nursing piglets at birth by active immunization of sows prior to farrowing with transmissible gastroenteritis vaccine and method of producing the same |
US3907987A (en) * | 1972-05-25 | 1975-09-23 | Canadian Patents Dev | Enteric disease vaccine |
US4132597A (en) * | 1976-06-09 | 1979-01-02 | Ab Medipharm | Method for cultivation of bacteria |
US4237218A (en) * | 1979-02-09 | 1980-12-02 | Bio-Rad Laboratories, Inc. | Micro-carrier cell culture |
JPS5991879A (ja) * | 1982-11-16 | 1984-05-26 | Hideaki Yamada | シユ−ドモナス属細菌の培養法 |
EP0138854B1 (en) | 1983-03-08 | 1992-11-04 | Chiron Mimotopes Pty. Ltd. | Antigenically active amino acid sequences |
DK594084A (da) * | 1984-12-12 | 1986-06-13 | Novo Industri As | Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning |
JPH0644865B2 (ja) * | 1985-10-29 | 1994-06-15 | 三菱瓦斯化学株式会社 | カンピロバクタ−属細菌の培養方法 |
US5338670A (en) * | 1986-07-28 | 1994-08-16 | The United States Of America As Represented By The Department Of Health And Human Services | Production of bordetella pertussis toxin with a low concentration of iron |
IT1227657B (it) * | 1988-12-01 | 1991-04-23 | Mini Ricerca Scient Tecnolog | Antibiotici ab-021 e processo per la loro produzione |
JPH0822221B2 (ja) * | 1988-12-28 | 1996-03-06 | 日東化学工業株式会社 | シュードモナス属細菌の培養法 |
JPH02308754A (ja) * | 1989-05-24 | 1990-12-21 | Yakult Honsha Co Ltd | 乳発酵食品の製造法 |
US5296221A (en) * | 1990-01-31 | 1994-03-22 | Sani-Ei Sucrochemical Co., Ltd. | Lactobacillus johnsonii ferm bp-2680 lactic acid bacteria preparations using the same and a process of manufacturing the preparations |
US5192679A (en) * | 1990-05-03 | 1993-03-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Growing ehrlichia species in a continuous cell line |
US5565205A (en) | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
WO1992007934A1 (en) * | 1990-11-01 | 1992-05-14 | Iowa State University Research Foundation, Inc. | Bacterial attenuation method and vaccine |
US6042830A (en) | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
US5580557A (en) * | 1991-10-09 | 1996-12-03 | Iowa State University Research Foundation, Inc. | Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals |
US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
DE4208785A1 (de) * | 1992-03-19 | 1993-09-23 | Degussa | Verfahren zum auffinden von insertionselementen (is-elemente) oder transposonen |
CA2145760A1 (en) | 1992-09-28 | 1994-04-14 | Balbir S. Bhogal | Method of enhancing cell mediated immune responses |
US5610059A (en) * | 1992-11-09 | 1997-03-11 | University Of Arizona | Etiological agent for porcine enteritis |
US5714375A (en) * | 1995-06-05 | 1998-02-03 | Nobl Laboratories, Inc. | Ileal symbiont intracellularis propagation in suspended host cells |
US5885823A (en) | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
BR9611623A (pt) | 1995-11-30 | 1999-12-28 | Daratech Pty Ltd | Composição de vacina e processo para a profilaxia ou tratamento de infecção em um animal ou pássaro por lawsonia intracelularis ou microorganismo relacionado, molécula de ácido nucleico isolada, e, vacina genética. |
ES2157522T3 (es) | 1996-10-09 | 2001-08-16 | Akzo Nobel Nv | Cepas de vacunas europeas del virus del sindrome respiratorio reproductor porcino (prrsv). |
JPH11171A (ja) * | 1997-06-10 | 1999-01-06 | Norin Suisansyo Kachiku Eisei Shikenjo | 豚丹毒菌の莢膜形成遺伝子群の塩基配列、それを利用した豚丹毒菌の弱毒株の作出方法および豚丹毒菌の鑑別方法 |
US6391314B1 (en) | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
US20060029617A1 (en) | 1997-10-03 | 2006-02-09 | Charreyre Catherine E | Porcine circovirus and Helicobacter combination vaccines and methods of use |
US7192594B2 (en) | 1997-10-03 | 2007-03-20 | Merial Limited | Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
FR2781159B1 (fr) | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
UA78180C2 (uk) | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
JP2992980B2 (ja) * | 1997-11-19 | 1999-12-20 | 農林水産省家畜衛生試験場長 | 豚丹毒菌の莢膜欠損変異株 ys−1株 |
US20040062775A1 (en) | 1997-12-05 | 2004-04-01 | Agence Francaise De Securite Sanitaire Des Aliments | Circovirus sequences associated with piglet weight loss disease (PWD) |
FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
RU2000118777A (ru) | 1997-12-11 | 2002-07-10 | Университи Оф Саскачеван (Ca) | Вирус синдрома мультисистемного истощения свиньи у поросят-отъемышей |
WO1999045956A1 (en) | 1998-03-13 | 1999-09-16 | University Of Georgia Research Foundation, Inc. | Vaccines against circovirus infections |
MXPA01011570A (es) | 1999-05-13 | 2003-08-20 | Australian Pork Ltd | Gen derivado de lawsonia y polipeptidos, peptidos y proteinas relacionadas con peptido h de membrana externa. |
WO2000069904A1 (en) | 1999-05-13 | 2000-11-23 | Pfizer Products Inc | LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
AU775323B2 (en) | 1999-05-13 | 2004-07-29 | Agriculture Victoria Services Pty Ltd | Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses |
AU4385800A (en) | 1999-05-13 | 2000-12-05 | Agriculture Victoria Services Pty Ltd | Lawsonia derived gene and related sodC polypeptides, peptides and proteins and their uses |
US20030157120A1 (en) * | 1999-05-13 | 2003-08-21 | Michael Panaccio | Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses |
US7052697B1 (en) * | 1999-05-13 | 2006-05-30 | Agriculture Victoria Services Pty Ltd | Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses |
US6764687B1 (en) * | 1999-06-09 | 2004-07-20 | Akzo Nobel N.V. | Live attenuated bacteria for use in a vaccine |
US6414036B1 (en) * | 1999-09-01 | 2002-07-02 | Van Beek Global/Ninkov Llc | Composition for treatment of infections of humans and animals |
US6605696B1 (en) * | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
EP1094070A3 (en) | 1999-10-22 | 2002-01-09 | Pfizer Products Inc. | Lawsonia intracellularis proteins, and related methods and materials |
US6656478B1 (en) | 1999-11-12 | 2003-12-02 | Samuel D. Charles | Cross-protective salmonella vaccines |
WO2002072015A2 (en) * | 2001-03-12 | 2002-09-19 | Montana State University-Bozeman | M cell directed vaccines |
JP2003533989A (ja) | 2000-05-24 | 2003-11-18 | メリアル | ブタ生殖・呼吸症候群ウィルス(prrsv)の組換えポックスウィルスワクチン |
MXPA02012352A (es) | 2000-06-15 | 2004-09-06 | Purdue Research Foundation | Vacuna para temblores congenitos en cerdos. |
MY128159A (en) * | 2000-06-30 | 2007-01-31 | Wyeth Corp | Methods and composition for oral vaccination |
CA2423588A1 (en) | 2000-09-29 | 2002-04-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Improved vaccines for proliferative ileitis and methods of making and using the same |
US20020103261A1 (en) * | 2000-10-06 | 2002-08-01 | Dusan Ninkov | Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals |
NZ520600A (en) | 2000-11-10 | 2004-08-27 | Agriculture Victoria Serv Pty | Novel therapeutic compositions for treating infection by Lawsonia spp |
US7018638B2 (en) * | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
MY129765A (en) | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
DE60120621T2 (de) * | 2000-12-20 | 2006-12-14 | Intervet International B. V. | Lawsonia intracellularis Impfstoff |
HU228065B1 (en) | 2001-03-27 | 2012-09-28 | Univ Saskatchewan | Methods to culture circovirus |
WO2003000665A1 (de) | 2001-06-22 | 2003-01-03 | Bayer Aktiengesellschaft | Antibakterielle uracilderivate. |
EA003573B1 (ru) | 2001-06-29 | 2003-06-26 | Александр Михайлович Ильянок | Плоский дисплей с самосканирующей разверткой |
NZ530106A (en) | 2001-07-02 | 2007-06-29 | Pfizer Prod Inc | One dose vaccination with mycoplasma hyopneumoniae with whole or partial cell inactivated preparation |
US20030087421A1 (en) * | 2001-07-11 | 2003-05-08 | Gebhart Connie J | Lawsonia intracellularis |
US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
AU2002951692A0 (en) | 2002-09-23 | 2002-10-17 | Vital Biotech (Hong Kong) Limited | Improvements in or relating to vaccines |
EP1570045A4 (en) | 2002-10-04 | 2007-09-05 | Univ Minnesota | NUCLEIC ACID AND POLYPEPTIDE SEQUENCES FROM LAWSONIA INTRACELLULARIS AND METHOD OF USE |
MXPA05008252A (es) | 2003-02-03 | 2006-05-22 | Cerebus Biolog Inc | Metodos para tratar, prevenir y detectar una infeccion con helicobacter. |
TWI238721B (en) | 2003-06-20 | 2005-09-01 | Animal Technology Inst Taiwan | Swine enzootic vaccine, its producing method and usage |
SI1651265T1 (sl) | 2003-07-24 | 2008-10-31 | Merial Ltd | Formulacije cepiva, ki obsegajo emulzijo olje v vodi |
PL1651260T5 (pl) | 2003-07-25 | 2018-11-30 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia intracellularis pochodzenia europejskiego oraz szczepionki, środki diagnostyczne i sposoby ją wykorzystujące |
US7361357B2 (en) * | 2003-07-29 | 2008-04-22 | Pfizer Inc. | Safe mutant viral vaccines |
EP1664100B1 (en) | 2003-09-12 | 2009-12-02 | Intervet International BV | Lawsonia intracellularis subunit vaccine |
CA2554472A1 (en) | 2004-01-22 | 2005-08-04 | Intervet International B.V. | Lawsonia intracellularis subunit vaccines |
MY146476A (en) | 2004-06-24 | 2012-08-15 | Boehringer Ingelheim Vetmed | Method of diagnosing lawsonia intracellularis |
JP5291281B2 (ja) | 2004-06-28 | 2013-09-18 | 株式会社渡辺商行 | 浮上搬送装置及び浮上搬送方法 |
US7550270B2 (en) * | 2004-08-13 | 2009-06-23 | Boehringer Ingelheim Vetmedica, Inc. | Ileitis diagnostic assay |
US20070212373A1 (en) * | 2004-12-08 | 2007-09-13 | Akzo Nobel N.V. | Lawsonia Intracellularis 26 Kd Subunit Vaccine |
US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
JP2008538502A (ja) | 2005-04-18 | 2008-10-30 | ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド | サブユニットワクチン中の構成成分として有用なローソニアタンパク並びにその製造方法及び使用方法 |
TW200716166A (en) * | 2005-04-28 | 2007-05-01 | Boehringer Ingelheim Vetmed | Lawsonia intracellularis immunological proteins |
US8398994B2 (en) * | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
AU2006289102C1 (en) | 2005-09-09 | 2017-11-30 | Intervet International B.V. | PCV-2 vaccine |
EP1792996A1 (en) | 2005-12-01 | 2007-06-06 | Consejo Superior de Investigaciones Cientificas | Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV) |
EP2275132B1 (en) | 2005-12-29 | 2021-03-03 | Boehringer Ingelheim Animal Health USA Inc. | Multivalent PCV2 immunogenic compositions and methods of producing them |
EP2275130A3 (en) | 2005-12-29 | 2011-03-23 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 ORF2 immunogenic composition |
US8470336B2 (en) * | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
US20080241190A1 (en) * | 2006-11-13 | 2008-10-02 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of horses against lawsonia intracellularis |
US20100136060A1 (en) | 2006-11-22 | 2010-06-03 | Boehringer Ingelheim Vetmedica, Inc. | Methods of reducing porcine circovirus-associated disease outbreaks |
EP2101815A4 (en) | 2006-12-11 | 2010-10-06 | Boehringer Ingelheim Vetmed | EFFICIENT PROCESS FOR THE TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS |
MX2009006066A (es) | 2006-12-15 | 2009-06-17 | Boehringer Ingelheim Vetmed | Tratamiento de cerdos con el antigeno pcv. |
EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
GB0712160D0 (en) | 2007-06-22 | 2007-08-01 | Univ Ghent | Methods and compositions in the treatment of procine circoviral infection |
US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
US8398970B2 (en) * | 2007-09-17 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Method of preventing early Lawsonia intracellularis infections |
BRPI0820341B1 (pt) | 2007-11-06 | 2021-11-09 | Zoetis Services Llc | Composição imunogênica para uso na proteção de um animal contra uma doença associada a uma cepa virulenta de mycoplasma hyopneumoniae |
BRPI0907438A2 (pt) | 2008-01-23 | 2015-08-04 | Boehringer Ingelheim Vetmed | Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições |
EP2254595A4 (en) | 2008-02-15 | 2012-12-05 | Boehringer Ingelheim Vetmed | METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES |
TWI449533B (zh) | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗 |
US8444989B1 (en) | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
US8142760B2 (en) * | 2008-09-05 | 2012-03-27 | Nathan Len Winkelman | Vaccination for Lawsonia intracellularis |
TWI627281B (zh) | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物 |
CN105246505A (zh) | 2013-04-30 | 2016-01-13 | 勃林格殷格翰动物保健公司 | PCV2a亚型(PCV2a)的ORF2蛋白用于交叉保护中的用途 |
-
2006
- 2006-03-13 US US11/374,350 patent/US8834891B2/en active Active
- 2006-03-14 EP EP17203632.9A patent/EP3354279A3/en active Pending
- 2006-03-14 DK DK15162413.7T patent/DK2992897T3/da active
- 2006-03-14 AU AU2006222906A patent/AU2006222906A1/en not_active Abandoned
- 2006-03-14 KR KR1020077023513A patent/KR101315092B1/ko active IP Right Grant
- 2006-03-14 DK DK06738652.4T patent/DK1865984T3/en active
- 2006-03-14 SG SG10202006681WA patent/SG10202006681WA/en unknown
- 2006-03-14 EP EP15162413.7A patent/EP2992897B1/en not_active Revoked
- 2006-03-14 BR BRPI0608439A patent/BRPI0608439B1/pt active IP Right Grant
- 2006-03-14 ES ES06738652.4T patent/ES2596307T3/es active Active
- 2006-03-14 ES ES15162413.7T patent/ES2688922T3/es active Active
- 2006-03-14 EP EP06738652.4A patent/EP1865984B1/en active Active
- 2006-03-14 CN CN2006800166161A patent/CN101175509B/zh active Active
- 2006-03-14 JP JP2008502078A patent/JP5832061B2/ja active Active
- 2006-03-14 SG SG2011068764A patent/SG175555A1/en unknown
- 2006-03-14 CA CA2600877A patent/CA2600877C/en active Active
- 2006-03-14 MX MX2007011268A patent/MX2007011268A/es active IP Right Grant
- 2006-03-14 EP EP21165358.9A patent/EP3906941A1/en active Pending
- 2006-03-14 WO PCT/US2006/009618 patent/WO2006099561A1/en active Application Filing
-
2007
- 2007-09-12 ZA ZA2007/07799A patent/ZA200707799B/en unknown
-
2013
- 2013-11-29 JP JP2013248272A patent/JP2014037449A/ja active Pending
-
2014
- 2014-07-31 US US14/447,694 patent/US9463231B2/en active Active
-
2016
- 2016-08-30 US US15/251,308 patent/US10201599B2/en active Active
-
2018
- 2018-12-19 US US16/226,518 patent/US10994004B2/en active Active
-
2020
- 2020-10-12 US US17/068,173 patent/US11738077B2/en active Active
-
2023
- 2023-05-17 US US18/318,933 patent/US20230302111A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200707799B (en) | Immunogenic compositions comprising lawsonia intracellularis | |
HUS2200002I1 (hu) | Immunogén készítmény | |
EP1874345A4 (en) | IMMUNOSTIMULANT COMPOSITIONS | |
GB0515052D0 (en) | Organosiloxane compositions | |
GB0506939D0 (en) | Organosiloxane compositions | |
GB0526038D0 (en) | Immunogenic composition | |
ZA200708581B (en) | Novel nutraceutical compositions | |
EP2018182A4 (en) | IMMUNOGENIC COMPOSITIONS | |
HK1204570A1 (en) | Compositions comprising nebivolol | |
ZA200710909B (en) | Immunogenic composition | |
ZA200710854B (en) | Immunogenic composition | |
GB0526041D0 (en) | Immunogenic composition | |
GB0503143D0 (en) | Immunogenic composition | |
GB0515556D0 (en) | Immunogenic composition | |
GB0524204D0 (en) | Immunogenic composition | |
GB0526040D0 (en) | Immunogenic composition | |
ZA200702752B (en) | Immunogenic compositions | |
GB0516239D0 (en) | Organosiloxane compositions |